title: Effect of rhCSF-1 on human hemopoiesis in long-term cultures from patients with acute myelogenous leukemia.
abstract: Bone marrow and/or peripheral blood cells from seven patients with acute myelogenous leukemia (AML) were maintained for 7 weeks in Dexter-type long-term culture (LTC) in order to study the effect of exogenous recombinant human colony-stimulating factor-1 (rhCSF-1) and to quantitate endogenous levels of CSF-1. rhCSF-1 was added every 2 days during the first 3 weeks of culture at 15 ng/ml. In all but one culture, adding rhCSF-1 inhibited putative leukemic hemopoiesis [i.e. decreased numbers of abnormal (blast) colony-forming cells and blasts] and stimulated putative normal hemopoiesis (increased numbers of CFU-GM and macrophages). Our data, however, do not distinguish direct effects of rhCSF-1 on normal or leukemic cells from indirect effects mediated by accessory cells. In cultures with a poorly formed adherent layer (all derived from patients classified as M5), the endogenous levels of CSF-1 were lower than those in cultures with a good (confluent) adherent layer, indicating that the levels of CSF-1 in LTC from AML patients positively correlate with the formation of the adherent layer. Our data indicate that CSF-1 is an important modulator of human hemopoiesis in LTC established from AML bone marrow or peripheral blood, and that rhCSF-1 might be valuable for purging leukemic cells in LTC established from AML patients' bone marrow or peripheral blood for autologous transplantation.
authors.affiliation: Department of Medicine, University of Alberta, Edmonton, Canada.
authors.forename: H
authors.initials: H
authors.lastname: Mayani
authors.forename: S Y
authors.initials: SY
authors.lastname: Shen
authors.forename: L J
authors.initials: LJ
authors.lastname: Guilbert
authors.forename: S C
authors.initials: SC
authors.lastname: Clark
authors.forename: I
authors.initials: I
authors.lastname: Sych
authors.forename: A
authors.initials: A
authors.lastname: Janowska-Wieczorek
mesh_terms: D006410:Hematopoiesis / Q000187:drug effects*; D006412:Hematopoietic Stem Cells / Q000187:drug effects; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000097:blood* / Q000473:pathology; D016173:Macrophage Colony-Stimulating Factor / Q000032:analysis / Q000494:pharmacology*; D011994:Recombinant Proteins / Q000494:pharmacology; D014407:Tumor Cells, Cultured
chemical_list: D011994:Recombinant Proteins; D016173:Macrophage Colony-Stimulating Factor